08 maj: Rapport for 1. kvartal 2019
09 maj: Indre værdi af SmallCap Danmark A/S er opgjort til 10,4 kr. pr. a..
09-05-2019 07:30:58

Three-month interim report (Q1) 2019

Strong sales growth in Q1 (unaudited)

In Q1, ALK had organic growth of 14% and continued to deliver on its growth strategy, which saw accelerated growth in tablet sales of 52% and further stabilisation of its legacy AIT business. Other products also performed well and growth was broad-based across all sales regions.

Q1 2019 highlights

  • Total revenue was up 14% in local currencies at DKK 867 million (752). Currencies positively affected growth by 1 percentage point and reported growth in DKK was therefore 15%.
  • SLIT-tablets sales were up 52% to DKK 256 million (168). SCIT/SLIT-drops stabilised and sales were therefore unchanged at DKK 495 million (490) while other products grew 18% to DKK 116 million (94).
  • Growth in all regions: Europe up 8%, North America up 11% and International markets up 198%.
  • Operating profit (EBITDA) was DKK 133 million (92), equivalent to an EBITDA-margin of 15%.
  • Free cash flow for the quarter was negative at DKK 17 million (minus 75).

Progress on the four strategic priorities

  • Commercialisation of the tablet portfolio gained further momentum as ALK continued to take advantage of market expansion and the general transition towards standardised, registered products, particularly in Europe and Japan. ALK continues to make investments in support of the tablet portfolio. Clinical development is progressing, and the European regulatory review of the tree SLIT-tablet is ongoing.
  • Long-term efforts to develop the SLIT-tablet opportunity in North America continue and are gradually delivering a growing acceptance among key prescribers along with improved prescription depth.
  • Patient engagement and Consumer Care division activities are making positive progress in the test markets of UK and Germany. Patient engagement tools (e.g. klara) are gaining popularity and are proving effective, and work continues to identify further adjacent opportunities through business development work.
  • Efficiency programmes continue to show results, and the portfolio and site strategy is progressing as planned.

      

2019 financial outlook

Full-year outlook has slightly improved compared with that stated in the annual report, which was released on 7 February 2019, and is now tracking towards the higher end of the original guidance range. The outlook for free cash flow has been refined.

  • Full-year revenue is projected to be DKK 3,100-3,300 million (2018: DKK 2.9 billion).
  • Operating profit (EBITDA) is expected at DKK 100-200 million (2018: DKK 136 million).
  • ALK will continue its investment programme to support the strategic transformation of the company.  
  • Free cash flow is now expected at DKK minus 400 million or better (previously: approximately DKK minus 400) (2018: minus DKK 294 million).

Hørsholm, 9 May 2019

ALK-Abelló A/S

Comparative figures for 2018 are shown in brackets. Growth rates are stated in local currencies, unless otherwise indicated

For further information, contact:

Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

Media: Jeppe Ilkjær, tel. +45 7877 4532, mobile +45 3050 2014

Today, ALK is hosting a conference call for analysts and investors at 1.30 p.m. (CEST) at which Management will review the financial results and the outlook. The conference call will be audio cast on https://ir.alk.net. Participants for the audio cast are kindly requested to call in before 1.25 p.m. (CEST). Danish participants should call in on tel. +45 3544 5577 and international participants should call in on tel. +44 333 300 0804 or +1 631 913 1422. Please use the Participant Pin Code: 23089148#. The conference call will also be webcast live on our website, where the related presentation will be made available shortly before the call begins.

Attachment

ALK_logo_GlobeNewsWire.png

Relateret indhold
15 aug - 
ALK/SHB: Kursmålet hæves til 1450 kr. fra 1283 kr.
14 aug - 
ALK-Abelló/Jefferies: Løfter kursmål til 1350 kr. fra 1..
14 aug - 
ALK-Abelló/SHB: Kursmål løftes til 1450 kr. fra 1283 kr..
Relateret debat
13 aug - 
Ja puha, var ved at falde ned af stolen da den lå 5% ne..
13 aug - 
-0,5% det kører bare...
12 aug - 
Nu har de lukket for handel 😉
Del

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Vestas' største kinesiske konkurrent oplever dyk i overskuddet

23-08-2019 15:14:38
Den kinesiske vindmølleproducent Goldwind, som er verdens næststørste af sin slags efter Vestas, måtte i første halvår se sit overskud skrumpe med 22,6 pct. til 1,18 mia. yuan.Omsætningen for perioden er opgjort til 15,73 mia. yuan, fremgår det af Bloomberg News.Goldwind havde i 2018 en markedsandel globalt på 14,7 pct. - og var dermed nummer to efter Vestas med en andel på 22,2 pct.Nummer tre var..

Kina gengælder amerikansk told: Aktiefutures falder

Relaterede nyheder
23-08-2019 14:27:22
Kina vil indføre told på 5-10 pct. på amerikanske varer for yderligere 75 mia. dollar som en gengældelse af amerikanernes told på varer, som importeres fra Kina.Tolden indføres i to etaper henholdsvis 1. september og 1. december.Det skriver Bloomberg News.Ifølge det kinesiske medie Xinhua varsler Kina også en told på 25 pct. på amerikanske biler fra 15. december, og sojaimporten fra USA pålægges e..

Sydbank sænker Ambu-anbefaling - flere finanshuse retter kursmål efter nedjustering

23-08-2019 11:27:06
Sydbank ser en aktie i Ambu som "mindre attraktiv" end tidligere, efter medicoselskabet senest i denne uge skar i forventningerne til resultaterne for hele 2018/19.Derfor sættes anbefalingen ned til "hold" fra "køb", skriver Søren Løntoft Hansen, senioraktieanalytiker i Sydbank.- I kølvandet på strategiopdateringen i juni og gårsdagens melding om investeringerne i det direkte salg i USA har vi sæn..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

ALK-Abelló B A/S 1,412.00 -1,5% Fald i aktiekurs

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. august 2019 18:34:03
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190819.1 - EUROWEB1 - 2019-08-25 18:34:03 - 2019-08-25 18:34:03 - 1 - Website: OKAY